Value Base’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Value Base’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-152,761	Closed	-$153K	–	7
2026 Q1	$153K	Hold	152,761	–	–	0.12%	7
2025 Q4	$51.9K	Hold	152,761	–	–	0.04%	8
2025 Q3	$52.7K	Hold	152,761	–	–	0.04%	7
2025 Q2	$36.7K	Hold	152,761	–	–	0.02%	7
2025 Q1	$36.3K	Hold	152,761	–	–	0.02%	8
2024 Q4	$32.1K	Buy	+152,761	New	+$31.2K	0.02%	8

Other funds holding DRTSW

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

CIA

Cohen Investment Advisors Bedford, New Hampshire $223M AUM 20.96% 1-Year Est. Return

EPM

Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

Value Base's DRTSW Position: Q2 2026 in Review

Value Base sold out of Alpha Tau Medical Warrant (DRTSW) in Q2 2026, closing a stake of 152,761 shares — an estimated $153K sold.

Value Base first reported a position in DRTSW in Q4 2024 and held it in 6 quarters. The position peaked at $153K in Q1 2026. 3 funds tracked by Wall St. Rank hold DRTSW as of Q2 2026.

Value Base reported no remaining Alpha Tau Medical Warrant position as of Q2 2026 after selling out during the quarter.
Value Base sold 152,761 Alpha Tau Medical Warrant shares in Q2 2026, an estimated $153K.
Value Base first reported a position in Alpha Tau Medical Warrant in Q4 2024 and held it in 6 quarters.
Value Base's Alpha Tau Medical Warrant position peaked at $153K in Q1 2026.
3 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2026.

Based on Value Base's 13F filing for Q2 2026, filed 29 Jul 2026.